Saturday, May 2, 2015
- 5:30pm-7:30pm
-
Early Use of Anti-Lymphocyte Antibody in Kidney Transplant Recipients With Delayed Graft Function Can Produce Desirable Post-Transplant Results
Poster Session A: Kidney Immunosuppression: Induction Therapy • Exhibit Hall E
- 5:30pm-7:30pm
-
Early Vs. Late Acute Antibody Mediated Rejection Among Renal Transplant Recipients in Terms of Its Response to Rituximab Therapy-Single Center Expereince
Poster Session A: Liver: Immunosuppression and Rejection • Exhibit Hall E
- 5:30pm-7:30pm
-
ECDI Fixed Donor Splenocytes Combined With α-1 Antitrypsin Induce Immune Tolerance in Mice Cardiac Transplantation Model
Poster Session A: Preclinical Immunosuppression and Tolerance • Exhibit Hall E
- 5:30pm-7:30pm
-
Eculizumab in the Treatment of Early Severe Acute Antibody Mediated Rejection Following HLA-Compatible Kidney Transplantation-Case Series
Poster Session A: Kidney Antibody Mediated Rejection • Exhibit Hall E
- 5:30pm-7:30pm
-
Effect of Antibody Mediated Rejection on Long-Term Renal Allograft Function
Poster Session A: Kidney Antibody Mediated Rejection • Exhibit Hall E
- 5:30pm-7:30pm
-
Effect of Everolimus on Cardiovascular Parameters in De Novo Kidney Transplant Recipients: 12-Month Results from the ELEVATE Study
Poster Session A: Kidney: Cardiovascular and Metabolic • Exhibit Hall E
- 5:30pm-7:30pm
-
Effect of Everolimus Versus Tacrolimus On Left Ventricular Hypertrophy in Renal Transplant Patients On Maintenance
Poster Session A: Kidney: Cardiovascular and Metabolic • Exhibit Hall E
- 5:30pm-7:30pm
-
Effect of Induction in Renal Transplant Recipients Aged 70 and Over
Poster Session A: Kidney Immunosuppression: Induction Therapy • Exhibit Hall E
- 5:30pm-7:30pm
-
Effects of Early Everolimus Use for Immunosuppression in Living Donor Liver Transplant Recipients- An Analysis of 215 Sequential Patients
Poster Session A: Liver: Immunosuppression and Rejection • Exhibit Hall E
- «Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 30
- Next Page»